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Purpose: To evaluate the serial changes in sexual function in the short-term period after 
holmium laser enucleation of the prostate (HoLEP) for benign prostatic hyperplasia 
(BPH) and to investigate whether a change in each domain of the International Index 
of Erectile Function (IIEF) is associated with improvement of micturition. 
Materials and Methods: Thirty-eight potent men who underwent HoLEP and in whom 
complete 12-month follow-up data on the IIEF were available were included in this ret-
rospective study. All patients underwent a baseline evaluation for BPH. The surgical 
outcome was evaluated at 1, 3, 6, and 12 months postoperatively by use of the 
International Prostate Symptom Score, IIEF, and uroflowmetry. 
Results: The mean age and body mass index of the patients was 64.5±6.2 years and 
24.2±2.6 kg/m
2, respectively. Mean total prostate volume and transitional zone volume 
were 48.8±18.8 ml and 24.2±16.1 ml, respectively. Most IIEF domain scores showed 
a slight decrease at 1, 3, and 6 months after surgery but recovered to the baseline or 
showed a marginal but nonsignificant increase at 12 months postoperatively compared 
with baseline. Orgasmic function and the overall sexual satisfaction domain score re-
mained slightly reduced up to 12 months postoperatively. There was no significant cor-
relation between improvement of micturition and change in sexual function throughout 
the follow-up period after surgery. 
Conclusions: Although HoLEP achieves significant improvements in micturition, over-
all sexual function decreases slightly in the early postoperative period, but recovers 
to the baseline at 12 months postoperatively. Our data suggest that changes in sexual 
function after HoLEP are not associated with improvement of micturition.
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INTRODUCTION 
With the increase in life expectancy, there has been a grow-
ing interest in age-related conditions such as lower urinary 
tract symptoms/benign prostatic hyperplasia (LUTS/ 
BPH) and sexual dysfunction in the past few years. 
Because LUTS/BPH and sexual dysfunction are highly 
prevalent conditions that have substantially adverse im-
pacts on quality of life (QoL) in elderly men, many studies 
have evaluated a causal relationship between LUTS/BPH 
and sexual function, although such a relationship remains 
controversial [1-6].
Because of the possible association between LUTS/BPH 
and sexual function, several studies have evaluated the in-
fluence of various treatments for LUTS/BPH on sexual 
function [6-12]. The previous studies on transurethral re-
section of the prostate (TURP), the reference standard of 
surgical treatment for LUTS/BPH, have shown mixed re-
sults in terms of postoperative sexual function [6-9,12].  
Recent studies that specifically evaluated sexual function 
following photoselective vaporization of the prostate (PVP) 
reported improvements or maintenance of sexual function Korean J Urol 2012;53:104-108
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TABLE 1. Baseline characteristics and perioperative variables 
for the 38 eligible patients
Mean±SD (range) or no. pts (%)
Baseline characteristics
Age (yr)     64.5±6.2 (51-75)
BMI kg/m
2            24.2±2.6 (20.0-31.3)
PSA ng/ml           3.1±3.2 (0.6-13.5)
Total prostate vol (ml)   48.8±18.8 (23-97)
Transition zone vol (ml) 24.2±16.1 (5-78)
Diabetes mellitus              11 (28.9)
Hypertension                5 (13.2)
Coronary artery disease              0 (0.0)
Perioperative variables
Resectoscope time (min)     94.4±47.0 (32-225)
Enucleation time (min)     68.5±29.8 (30-170)
Morcellation time (min) 14.5±13.7 (2-60)
Duration of catheterization (d)   2.5±1.8 (1-7)
Hospital stay (d)   3.4±1.3 (2-8)
Weight of tissue retrieved (g)       22.1±14.7 (3.0-57.1)
BMI, body mass index; PSA, prostate-specific antigen; Resecto-
scope time, the time that the resectoscope sheath was in place.
after surgery [10,13,14]. Also, recent studies on holmium 
laser enucleation of the prostate (HoLEP), an attractive al-
ternative to TURP, have shown no significant changes in 
overall sexual function at one or two time points of fol-
low-up after surgery [11,15].
To date, however, data are sparse on the serial changes 
in sexual function in the short-term period following 
HoLEP as assessed by use of validated tools. We therefore 
aimed to evaluate the serial changes in sexual function in 
the short-term period after HoLEP for LUTS/BPH by use 
of the International Index of Erectile Function (IIEF) and 
to investigate whether a change in each domain of the IIEF 
was associated with improvement of micturition.  
MATERIALS AND METHODS 
1. Study design 
Approval for this study was provided by the Internal 
Review Board of our Hospital. Of 95 potent men who under-
went HoLEP for LUTS/BPH refractory to medical therapy 
with an alpha-blocker between July 2008 and April 2009 
by a single surgeon, complete 12-month follow-up data on 
the IIEF were available for 53 patients. After excluding pa-
tients 1) who had a history of previous prostatic surgery, 
2) with urethral stricture or neurogenic bladder or pro-
static malignancy, or 3) who did not have sexual inter-
course within 4 weeks before surgery or each follow-up vis-
it, a total of 38 patients were eligible for analysis. 
All patients underwent a baseline evaluation with the 
IIEF, transrectal ultrasonography (TRUS), and multi-
channel video urodynamic study (MMS UD-2000; Medical 
Measurement System, Ennschede, The Netherlands) in 
addition to a general standard evaluation for LUTS/BPH 
including history, physical examination including digital 
rectal examination, International Prostate Symptom 
Score (IPSS), and serum prostate-specific antigen (PSA). 
After HoLEP, surgical outcomes of the treatment for 
LUTS/BPH were assessed at 1, 3, 6, and 12 months post-
operatively by use of the IIEF, IPSS, uroflowmetry, and 
post-void residual urine volume (PVR). Retrograde ejacu-
lation was documented by an urologist on the basis of the 
medical history at the follow-up visit. 
2. Intervention 
All surgical procedures were performed in a routine manner 
as previously described in detail [16]. Briefly, the first step 
was the exposure of the surgical capsule by incisions at the 
5 and 7 o’clock positions just above the verumontanum. 
These incisions were connected to each other in the shape 
of an inverted “U” by an incision at the 6 o’clock position. 
The median lobe was then enucleated along the surgical 
capsule in a retrograde fashion. The surgical capsule in the 
12 o’clock position of the apex was exposed through a mid-
line incision, which was extended from the bladder neck to 
the apex. The incision was then connected from the lateral 
edge to the 12 o’clock position and retrograde enucleation 
of the lateral lobes was performed. Morcellation of three 
enucleated lobes was performed in a routine manner. At the 
end of surgery, a 20 Fr three-way urethral Foley catheter 
was placed, and the balloon was inflated with 30 ml of saline. 
3. Statistical analysis 
Change in serial sexual function was evaluated by compar-
ing the total IIEF score as well as each individual domain 
score between baseline and each follow-up after surgery by 
use of the paired t-test. To systemically monitor changes 
in erectile function over time after surgery, the severity of 
erectile dysfunction (ED) in the patients was stratified into 
the following five categories according to the erectile func-
tion (EF) domain score of the IIEF: no ED (EF domain score 
26 to 30), mild ED (EF score, 22 to 25), mild to moderate 
ED (EF score, 17 to 21), moderate ED (EF score, 11 to 16), 
and severe ED (EF score, 6 to 10) [17]. The proportional 
changes in each category were analyzed throughout the fol-
low-up period after HoLEP. We used the Pearson correla-
tion test to assess the significance of correlations between 
change in each IIEF domain score and that in each variable 
of IPSS or uroflowmetry. A 5% level of significance was used 
for all statistical testing, and all statistical tests were 
two-sided. SPSS ver. 17.0 (SPSS Inc., Chicago, IL, USA) 
was used for the data analysis. 
RESULTS 
1. Baseline characteristics and perioperative variables 
The baseline characteristics and perioperative variables 
are shown in Table 1. Mean age and body mass index of all 
eligible patients were 64.5±6.2 years and 24.2±2.6 kg/m
2, 
respectively. Mean serum PSA, total prostate volume, and 
transitional zone volume were 3.1±3.2 ng/ml, 48.8±18.8 
ml, and 24.2±16.1 ml, respectively. Seven (18.4%) patients Korean J Urol 2012;53:104-108
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TABLE 2. Baseline values and HoLEP outcome according to the IIEF, IPSS, and uroflowmetry with PVR (Mean±SD)
Baseline 1 mo 3 mo 6 mo 12 mo
IIEF domain
Erectile function 20.1±7.2  19.7±7.2  18.9±6.0  18.7±7.0  23.8±3.9
Sexual desire   6.0±1.7    5.3±1.7    5.3±1.6    5.6±1.7    6.3±1.3
Orgasmic function   7.2±2.8    5.1±2.2    5.8±2.7     4.7±1.6
a    6.4±2.4
Intercourse satisfaction   7.9±2.4    6.7±2.1    7.1±2.2    6.8±2.4    8.7±1.8
Overall sexual satisfaction   6.4±2.1    5.1±1.7    5.5±1.6     5.2±1.8
a    6.0±1.2
Total sum   47.6±15.0    41.9±13.4    42.6±11.7    41.1±13.3  49.2±8.2
IPSS
Voiding symptoms 12.0±5.0     6.1±4.7
a     4.7±5.2
a     3.8±5.3
a     3.1±2.8
a
Storage symptoms   7.8±3.5    7.4±3.3     5.6±3.1
a     4.3±2.8
a     4.4±2.5
a
Total IPSS 18.9±7.3   13.5±5.9
a   10.3±6.8
a     8.2±6.9
a     7.4±4.3
a
QoL index   4.3±0.9     3.2±1.7
a     2.8±1.5
a     2.1±1.8
a     1.6±1.4
a
Uroflowmetry with PVR
Qmax, ml/s 12.3±4.9   20.0±9.6
a   19.1±9.7
a   20.4±6.6
a    19.7±9.6
a
PVR, ml   62.1±87.7     18.5±18.3
a     12.4±16.8
a     10.3±15.3
a    14.4±8.3
a
Values are presented as mean±SD.
HoLEP, holmium laser enucleation of the prostate; IIEF, International Index of Erectile Function; IPSS, International Prostate 
Symptom Score; PVR, post-void residual urine volume; QoL, quality of life; Qmax, maximum flow rate.
a: p＜0.05; Comparison between the baseline parameters and parameters obtained after HoLEP by use of the paired t-test. 
FIG. 1. Prevalence and severity of erectile dysfunction according 
to the follow-up period after holmium laser enucleation of the 
prostate. ED, erectile dysfunction.
received medication with 5-alpha reductase inhibitors be-
fore surgery. There were no major intraoperative complica-
tions such as severe bleeding requiring blood transfusion, 
but capsular perforation, bladder mucosal injury, de novo 
stress urinary incontinence, and de novo urgency urinary 
incontinence were observed in 1, 4, 1, and 6 cases, respec-
tively. Twenty (52%) patients complained of retrograde 
ejaculation after the surgery. 
2. Serial changes in micturition parameters and sexual 
function after HoLEP 
Table 2 summarizes the subjective and objective outcomes 
after HoLEP. As expected, both subtotal voiding symptom 
scores and total IPSS scores were significantly reduced 
compared with baseline starting from 1 month after the 
HoLEP procedure, which was associated with a significant 
improvement in the QoL index. In contrast, the subtotal 
storage symptom scores were significantly reduced com-
pared with baseline starting from 3 months after surgery. 
All IIEF domain scores showed a slight decrease at 1, 3, and 
6 months after surgery compared with baseline, although 
these changes were not statistically significant except for 
the orgasmic function and overall sexual satisfaction do-
main scores at 6 months after HoLEP. Also, at 12 months 
after HoLEP, all IIEF domain scores except for orgasmic 
function and overall sexual satisfaction recovered to the 
baseline or showed a marginal but nonsignificant increase 
compared with baseline. In contrast, both orgasmic func-
tion and overall sexual satisfaction domain scores were 
still slightly decreased at the 12-month follow-up com-
pared with baseline, but this was not statistically 
significant. Of the two items that compose the orgasmic 
function domain, the score of “ejaculation frequency” at 1, 
3, and 6 months after HoLEP was significantly decreased 
compared with baseline (p＜0.05). Even at 12 months after 
surgery, the score of “ejaculation frequency” was still 
slightly reduced compared with baseline, but this was not 
statistically significant (p=0.070). 
3. Prevalence and severity of ED according to the follow-up 
period after HoLEP 
Fig. 1 shows the prevalence and severity of ED according 
to the follow-up period after HoLEP. The percentages of pa-
tients with erectile dysfunction before surgery and at 1, 3, 
6, and 12 months after HoLEP were 73.7%, 78.9%, 81.6%, 
78.9%, and 71.1%, respectively. The percentages of pa-
tients with normal EF or mild ED at 1, 3, and 6 months after 
surgery were slightly decreased compared with baseline, 
whereas the percentages of patients with mild-to-moder-Korean J Urol 2012;53:104-108
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ate or moderate ED were slightly increased, but not sig-
nificantly so. In contrast, the percentage of patients with 
normal EF or mild ED at 12 months after surgery was 
slightly increased compared with baseline, whereas the 
percentage of patients with moderate or severe ED was 
slightly decreased, which was not statistically significant. 
4. Correlation between changes in micturition and sexual 
function 
We performed the Pearson correlation test to assess wheth-
er change in sexual function after HoLEP was associated 
with improvement in micturition symptoms. There was no 
significant correlation between improvement in each vari-
able of the IPSS or uroflowmetry and change in each IIEF 
domain score during the entire period of follow-up after the 
HoLEP procedure.  
DISCUSSION 
There are several data in the published literature evaluat-
ing the effect of HoLEP for LUTS/BPH on sexual function 
[11,15,18-21]. However, some studies used nonvalidated 
tools for evaluation of postoperative sexual function, and 
even other studies that used validated questionnaires did 
not analyze serial changes in the individual items or each 
domain score of the questionnaires in the early post-
operative period after HoLEP. To our knowledge, our study 
is the first to evaluate serial changes in sexual function by 
use of a validated questionnaire in the short-term, early 
postoperative period after HoLEP. Thus, our data can ex-
tend the current state of knowledge in the area of sexual 
function after BPH surgery by further exploring the serial 
changes in sexual function in the early postoperative peri-
od after HoLEP. The important findings of our study can 
be summarized as follows: 1) overall sexual function was 
slightly deteriorated in the early postoperative period after 
HoLEP, but recovered to the baseline at 1 year post-
operatively; 2) different from other IIEF domain scores, the 
orgasmic function or overall sexual satisfaction domain 
score was slightly decreased and this decrease lasted up to 
12 months following HoLEP, probably due to ejaculatory 
problems; 3) there was no significant correlation between 
improvement of micturition and change in sexual function 
throughout the follow-up period after HoLEP.
As suggested by our results, sexual function appears to 
be transiently decreased in the early postoperative period 
after HoLEP. Uygur et al. [22] showed that ED developed 
in 5% and 6% of potent patients at 3 months after open pros-
tatectomy or TURP, respectively, but that EF recovered in 
about half of them at 6 months postoperatively. Also, a pre-
vious study by Tscholl et al. [23] using the snap-gauge test 
at 4 days and 3 months after TURP showed a high rate of 
ED in the immediate postoperative period, which sig-
nificantly improved at retesting. A recent study by Choi et 
al. [24] showed that the EF domain score was decreased at 
1 and 3 months after TURP but recovered to the baseline 
at 6 months after surgery. Thus, the ED seen immediately 
after BPH surgery may be temporary and due to the neu-
rapraxia induced by thermal injury or emotional stress 
[15]. This is supported by the result of a study by Zohar et 
al. [25] showing that patients with LUTS/BPH reportedly 
tend to be anxious and less satisfied with their sexual life 
and that the level of anxiety exhibited by the patient is a 
predictor of potency after prostatectomy. Furthermore, 
Meng et al. [11] suggested that injury to the urethra could 
affect patients as pain during erection after HoLEP.
Another interesting finding was that the orgasmic func-
tion or overall sexual satisfaction domain score remained 
slightly decreased throughout the follow-up period after 
the HoLEP procedure. In the present study, the scores of 
“ejaculation frequency,” one of two items that compose the 
orgasmic function domain, were decreased throughout the 
follow-up period after HoLEP compared with baseline, al-
though not significantly so at 12 months after surgery. 
Therefore, ejaculatory problems may have an adverse ef-
fect on orgasmic function or overall sexual satisfaction af-
ter HoLEP. This finding is in accordance with the study by 
Briganti et al. [15] showing a significant deterioration in 
the mean IIEF orgasmic function domain score after 
HoLEP and a recent study by Muntener et al. [12] suggest-
ing that the loss of ejaculatory function after TURP is sig-
nificant and is associated with considerable bother.
The present study did not demonstrate a significant cor-
relation between improvement of micturition and change 
in sexual function after HoLEP. Although some studies 
have shown a correlation between LUTS/BPH and sexual 
dysfunction [2-5,26], the epidemiologic data do not support 
a causal relationship based on Hill’s criteria for causality 
between the two. Thus, it remains unclear whether sexual 
dysfunction in older men is causally related to BPH or is 
merely a consequence of aging [27]. Moreover, the evalua-
tion of sexual function in patients treated with TURP or 
PVP has been associated with mixed results [6-10,12-14]. 
Thus, the effect of BPH surgery on sexual function is still 
controversial. In accordance with our results, most recent 
studies have demonstrated no significant effect of HoLEP 
on sexual function after surgery in patients with LUTS/ 
BPH [18-21].
Some limitations of our study warrant consideration. 
First, the present study is limited by both its retrospective 
nature and the fact that it was conducted at a single in-
stitution and therefore carries with it all the inherent po-
tential issues associated with such studies. Second, the fol-
low-up period was only in the short-term. However, alter-
ations of sexual function more than 1 year after surgery 
may be significantly attributed to aging and comorbidities 
rather than the HoLEP procedure. Third, although retro-
grade ejaculation was queried at every follow-up visit, the 
IIEF cannot assess this condition completely. Fourth, our 
population was not large enough to perform an analysis in 
subgroups such as patients with no or mild ED or to allow 
for multivariate analysis. However, our data can be used 
to counsel patients regarding realistic expectations of sex-
ual function after the HoLEP procedure.  Korean J Urol 2012;53:104-108
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CONCLUSIONS 
Although HoLEP achieves significant improvements in 
micturition both subjectively and objectively, overall sex-
ual function decreases slightly in the early postoperative 
period after but recovers to baseline at 12 months posto-
peratively. In addition, our data suggest that changes in 
sexual function after HoLEP are not associated with im-
provement of micturition symptoms. However, studies 
with larger cohorts including prospective, multicenter 
studies are necessary to fully validate these findings.  
CONFLICTS OF INTEREST
The authors have nothing to disclose.
REFERENCES 
1. Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs R, Fourcade 
R, et al. The association between lower urinary tract symptoms 
and erectile dysfunction in four centres: the UrEpik study. BJU 
Int 2003;92:719-25.
2. Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, 
et al. Lower urinary tract symptoms and male sexual dysfunction: 
the multinational survey of the aging male (MSAM-7). Eur Urol 
2003;44:637-49. 
3. Hoesl CE, Woll EM, Burkart M, Altwein JE. Erectile dysfunction 
(ED) is prevalent, bothersome and underdiagnosed in patients 
consulting urologists for benign prostatic syndrome (BPS). Eur 
Urol 2005;47:511-7. 
4. Braun MH, Sommer F, Haupt G, Mathers MJ, Reifenrath B, 
Engelmann UH. Lower urinary tract symptoms and erectile dys-
function: co-morbidity or typical “Aging male” symptoms? Re-
sults of the “Cologne Male Survey”. Eur Urol 2003;44:588-94.
5. Elliott SP, Gulati M, Pasta DJ, Spitalny GM, Kane CJ, Yee R, et 
al. Obstructive lower urinary tract symptoms correlate with erec-
tile dysfunction. Urology 2004;63:1148-52. 
6. Leliefeld HH, Stoevelaar HJ, McDonnell J. Sexual function be-
fore and after various treatment for symptomatic benign pro-
static hyperplasia. BJU Int 2002;89:208-13. 
7. Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, 
Henderson WG. A comparison of transurethral surgery with 
watchful waiting for moderate symptoms of benign prostatic 
hyperplasia. The Veterans Affairs Cooperative Study Group on 
Transurethral Resection of the Prostate. N Engl J Med 1995;332: 
75-9. 
8. Parsons CI. Impotence following transurethral resection of the 
prostate. In: Rajfer J, editor. Common problems in infertility and 
impotence. 1st ed. Chicago: Year Book Medical; 1990;352-5.
9. Poulakis V, Ferakis N, Witzsch U, de Vries R, Becht E. Erectile 
dysfunction after transurethral prostatectomy for lower urinary 
tract symptoms: Results from a center with over 500 patients. 
Asian J Androl 2006;8:69-74. 
10. Paick JS, Um JM, Kim SW, Ku JH. Influence of high-power potas-
sium-titanyl-phosphate photoselective vaporization of the pros-
tate on erectile function: a short-term follow-up study. J Sex Med 
2007;4:1701-7. 
11. Meng F, Gao B, Fu Q, Chen J, Liu Y, Shi B, et al. Change of sexual 
function in patients before and after Ho:YAG laser enucleation 
of the prostate. J Androl 2007;28:259-61. 
12. Muntener M, Aellig S, Kuettel R, Gehrlach C, Sulser T, Strebel 
RT. Sexual function after transurethral resection of the prostate 
(TURP): results of an independent prospective multicentre as-
sessment of outcome. Eur Urol 2007;52:510-5. 
13. Bruyère F, Puichaud A, Pereira H, Faivre d'Arcier B, Rouanet A, 
Floc'h AP, et al. Influence of photoselective vaporization of the 
prostate on sexual function: results of a prospective analysis of 
149 patients with long-term follow-up. Eur Urol 2010;58:207-11. 
14. Kavoussi PK, Hermans MR. Maintenance of erectile function af-
ter photoselective vaporization of the prostate for obstructive be-
nign prostatic hyperplasia. J Sex Med 2008;5:2669-71. 
15. Briganti A, Naspro R, Gallina A, Salonia A, Vavassori I, Hurle R, 
et al. Impact on sexual function of holmium laser enucleation ver-
sus transurethral resection of the prostate: results of a pro-
spective, 2-center, randomized trial. J Urol 2006;175:1817-21. 
16. Cho MC, Park JH, Jeong MS, Yi JS, Ku JH, Oh SJ, et al. Predictor 
of de novo urinary incontinence following holmium laser enuclea-
tion of the prostate. Neurourol Urodyn 2011;30:1343-9. 
17. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. 
Diagnostic evaluation of the erectile function domain of the 
International Index of Erectile Function. Urology 1999;54: 
346-51. 
18. Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo 
R, et al. Holmium laser enucleation the prostate versus open pros-
tatectomy for prostates ＞70 g: 24-month follow-up. Eur Urol 
2006;50:563-8. 
19. Kuntz RM, Ahyai S, Lehrich K, Fayad A. Transurethral holmium 
laser enucleation of the prostate versus transurethral electro-
cautery resection of the prostate: a randomized prospective trial 
in 200 patients. J Urol 2004;172:1012-6. 
20. Tan AH, Gilling PJ, Kennett KM, Frampton C, Westenberg AM, 
Fraundorfer MR. A randomized trial comparing holmium laser 
enucleation of the prostate with transurethral resection of the 
prostate for the treatment of bladder outlet obstruction secondary 
to benign prostatic hyperplasia in large glands (40 to 200 grams). 
J Urol 2003;170:1270-4. 
21. Aho TF, Gilling PJ, Kennett KM, Westenberg AM, Fraundorfer 
MR, Frampton CM. Holmium laser bladder neck incision versus 
holmium enucleation of the prostate as outpatient procedures for 
prostates less than 40 grams: a randomized trial. J Urol 
2005;174:210-4. 
22. Uygur MC, Gür E, Arik AI, Altuğ U, Erol D. Erectile dysfunction 
following treatments of benign prostatic hyperplasia: a pro-
spective study. Andrologia 1998;30:5-10. 
23. Tscholl R, Largo M, Poppinghaus E, Recker F, Subotic B. 
Incidence of erectile impotence secondary to transurethral re-
section of benign prostatic hyperplasia, assessed by preoperative 
and postoperative Snap Gauge tests. J Urol 1995;153:1491-3. 
24. Choi SB, Zhao C, Park JK. The effect of transurethral resection 
of the prostate on erectile function in patients with benign pro-
static hyperplasia. Korean J Urol 2010;51:557-60. 
25. Zohar J, Meiraz D, Maoz B, Durst N. Factors influencing sexual 
activity after prostatectomy: a prospective study. J Urol 1976; 
116:332-4. 
26. Laumann EO, West S, Glasser D, Carson C, Rosen R, Kang JH. 
Prevalence and correlates of erectile dysfunction by race and eth-
nicity among men aged 40 or older in the United States: From the 
male attitudes regarding sexual health survey. J Sex Med 
2007;4:57-65.
27. Costabile RA, Steers WD. How can we best characterize the rela-
tionship between erectile dysfunction and benign prostatic hy-
perplasia? J Sex Med 2006;3:676-81.  